Jiangsu Jibeier Pharmaceutical Co.,Ltd.’s Net Profit Rose 33.1% in First Quarter of 2023
Listen to the full version

Jiangsu Jibeier Pharmaceutical Co.,Ltd. (江苏吉贝尔药业股份有限公司) (688566.SH) reported a net profit of 37.9 million yuan in the first quarter of 2023, up 33.1% year-on-year.
Meanwhile, the company posted 165.3 million yuan in revenue, up 19.1% year-on-year.
At the end of the reporting period, it had 2 billion yuan in total assets and 226.9 million yuan in total liabilities, with a liability-to-asset ratio of 11.6%.
Unlock exclusive discounts with a Caixin group subscription — ideal for teams and organizations.
Subscribe to both Caixin Global and The Wall Street Journal — for the price of one.
- PODCAST
- MOST POPULAR